Medtech
Inspire Medical Systems is expanding its reach in the UK with the announcement of 12 centres offering access to UK NHS and elective patients to its sleep apnoea technology. The move will contribute to a global usage of over 125,000 patients. The company, founded by Tim Herbert, in the USA, has developed a widely successful [...]
Surgical Holdings is inviting healthcare professionals to join its upcoming free, CPD-accredited webinar, Back to Basics: Surgical Retractors, taking place on Friday, 20 March at 12:00 pm. Delivered as part of the Surgical Holdings Academy, the session is designed to provide practical, real-world insights into one of the most commonly used yet often overlooked categories [...]
Boston Scientific Corporation today announced positive 12-month primary endpoint results from the VAPEUR clinical trial comparing Rezūm Water Vapour Therapy to dual drug therapy, also referred to as combination therapy, for the treatment of symptomatic benign prostatic hyperplasia (BPH) in sexually active men. Key findings from the study, presented at the annual European Association of [...]
MiniMed began trading on Nasdaq on Friday after Medtronic's diabetes tech spinoff raised US$560m in its initial public offering. The company listed under the ticker "MMED" after offering 28 million shares at US$20 each. That was below the US$25 to US$28 a share range the company had suggested in filings last month. MiniMed [...]
A pioneering implantable technology - often described as a ‘sleep apnoea pacemaker’ – has been introduced to the UK, offering an alternative treatment option for people living with moderate-to-severe obstructive sleep apnoea (OSA) who are unable to tolerate conventional therapies such as CPAP. Designed to prevent airway collapse during sleep, the technology works by gently [...]
Minnesota Medical Technologies has raised US$20.6m to launch its StaySure device for fecal incontinence in the US, offering an alternative to absorbent products. The company, founded in 2015, developed StaySure in collaboration with Mayo Clinic gastroenterologist Adil Bharucha. The single-use device is intended as an alternative to absorbent products such as adult nappies and pads, [...]
McDermott Will & Schulte has advised Groupe Bruxelles Lambert (“GBL”) in connection with its strategic investment in Rayner, a leading ophthalmic MedTech specialist. GBL has signed definitive agreements to acquire a 45% co‑control stake in Rayner. Under the transaction, GBL will invest €0.5 billion of equity alongside incumbent shareholders, including CVC and the Rayner management [...]
Munich-based Noxon has secured seed funding to advance its muscle-computer interface, a wearable technology designed to monitor and stimulate muscles during therapy. The medtech startup, founded in 2022 as a spin-off from three universities, is developing a device that combines continuous muscle monitoring with neuromuscular electrical stimulation (NMES). NMES is a therapy that uses small [...]
McDermott Will & Schulte advised Fidia Farmaceutici S.p.A. on its acquisition of Altacor Ltd, a UK‑based ophthalmic products company. The transaction marks a significant strategic step for Fidia as it enters the UK ophthalmology market directly, enhancing its presence in one of the group’s core therapeutic areas. Through the acquisition, Fidia expands its portfolio with [...]
LTIMindtree has secured a seven-year US$100m medtech deal to develop and support hearing aids and related digital tools for a European medical technology company. The Indian IT services company said the Europe-based client, which provides hearing solutions, has not been named. Under the agreement, LTIMindtree will develop and support the client’s main hearing [...]
